Chris Winchester is a strategic communications specialist and Managing Director of Oxford PharmaGenesis, an independent HealthScience communications consultancy. Chris enjoys developing global medical communication programmes on behalf of pharmaceutical and biotechnology clients, as well as professional societies, patient groups and academia. He has built strong relationships with leading experts in a range of therapeutic areas over the past 15 years. Chris completed a DPhil in Biochemistry at the Medical Research Council Immunochemistry Unit, University of Oxford. He holds an honorary academic position at Durham University, and has served on the European Committee of the International Society for Medical Publication Professionals (2011–2012). Oxford PharmaGenesis received a Queen’s Award for Enterprise in 2015 for outstanding achievement in international trade, and won a Communiqué Award for Excellence in Corporate Social Responsibility in 2016.